300147 香雪製藥
按盤價 
7.120 +0.390 (+5.795%)
7.120 +0.390 (+5.795%) | 2024/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,096,543 | -8.72% | 2,299,288 | 2,187,070 | 2,970,576 | 3,072,091 | |
| 減：營業總成本 | 1,186,186 | -2.90% | 2,452,474 | 2,575,669 | 3,167,436 | 2,904,528 | |
| 其中:營業成本 | 734,137 | -2.59% | 1,509,521 | 1,643,173 | 2,189,989 | 2,079,524 | |
| 財務費用 | 111,761 | -11.55% | 241,471 | 212,510 | 202,750 | 142,125 | |
| 資產減值損失 | (1,019) | -97.66% | (163,342) | (138,578) | (482,077) | (13,448) | |
| 公允價值變動收益 | (58) | -37.95% | 2,728 | (12) | 15,641 | (9,051) | |
| 投資收益 | (5,048) | -652.72% | (50,640) | 47,329 | 33,589 | 29,681 | |
| 其中：對聯營企業和合營企業的投資收益 | (310) | -134.35% | (52,159) | 903 | (19,543) | (9,228) | |
| 營業利潤 | (84,231) | 106.93% | (332,716) | (464,142) | (575,277) | 201,939 | |
| 利潤總額 | (115,707) | 98.60% | (388,951) | (511,864) | (622,344) | 138,829 | |
| 減：所得稅費用 | 5,172 | 3,867.33% | 12,795 | (7,215) | 24,458 | 23,160 | |
| 淨利潤 | (120,879) | 107.02% | (401,746) | (504,648) | (646,801) | 115,670 | |
| 減：非控股權益 | 14,342 | 88.64% | (12,782) | 25,410 | 29,772 | 43,376 | |
| 股東淨利潤 | (135,221) | 104.90% | (388,964) | (530,058) | (676,573) | 72,293 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.200 | 100.00% | -0.590 | -0.800 | -1.020 | 0.110 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 2.706 | -20.03% | 2.911 | 3.637 | 4.454 | 5.467 | |
| 審計意見 # | -- | 保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
